DexCom Reports Better-Than-Expected Q4 Results: Details

Core Viewpoint - DexCom reported strong quarterly earnings and revenue, exceeding analyst expectations, and reaffirmed its revenue outlook for fiscal 2026 [2]. Financial Performance - Quarterly earnings were reported at 68 cents per share, surpassing the Street estimate of 65 cents [2]. - Quarterly revenue reached $1.26 billion, slightly above the analyst estimate of $1.25 billion [2]. - U.S. revenue increased by 11% year-over-year, while international revenue grew by 18% on a reported basis [2]. Future Outlook - The company affirmed its fiscal 2026 revenue outlook, projecting a range of $5.16 billion to $5.25 billion [2]. Stock Performance - DexCom stock rose by 0.57% to $65.46 in extended trading [3].